Roche Announces $50B US Investment Plan to Avoid Tariffs
In what is a major development for the industry, Switzerland-based pharmaceutical giant Roche has announced a $50 billion investment plan in the US. Indeed, the company is set to increase its presence in the country to avoid the ongoing threat of tariffs on the sector. The investment should be massive for the economy, creating more than 12,000 jobs, according to a press release. Moreover, the move comes after US President Trump said that he would no longer exempt the industry from facing import duties. That decision has many companies in the sector looking for much-needed protections. JUST IN: Swiss pharmaceutical giant Roche to invest $50 billion in the United States to avoid tariffs. — Watcher.Guru (@WatcherGuru) April 23, 2025 Also Read: Trump: “Tariffs are Going Well, Everybody Wants to Negotiate” Roche Announces Major US Investment as Pharmaceutical Firm Eyes Tariff Protection For much of April, the global economy has sought ways to deal with the United States’ new Liberation...